Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.
about
Paired Expression Analysis of Tumor Cell Surface Antigens.Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA.Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial
P2860
Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.
@en
type
label
Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.
@en
prefLabel
Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.
@en
P2093
P2860
P356
P1433
P1476
Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.
@en
P2093
Jacob L Goldberg
Paul M Sondel
Zulmarie Perez Horta
P2860
P304
P356
10.2217/IMT-2016-0021
P577
2016-09-01T00:00:00Z